The Technical Analyst
Select Language :
Entrada Therapeutics, [TRDA]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Entrada Therapeutics, Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Entrada Therapeutics, is listed at the  Exchange

-1.25% $14.17

America/New_York / 28 mar 2024 @ 16:00


Entrada Therapeutics,: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 476.13 mill
EPS: -0.200
P/E: -70.85
Earnings Date: May 09, 2024
SharesOutstanding: 33.60 mill
Avg Daily Volume: 0.0779 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Neutral
DE: Buy
P/E: Strong Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -70.85 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-12.05x
Company: PE -70.85 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 13.20 - 15.14

( +/- 6.83%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-26 Kim Peter S Buy 2 750 Common Stock
2024-03-25 Kim Peter S Buy 3 180 Common Stock
2024-03-22 Kim Peter S Buy 3 118 Common Stock
2024-03-21 Kim Peter S Buy 704 Common Stock
2024-03-20 Kim Peter S Buy 1 128 Common Stock
INSIDER POWER
68.13
Last 99 transactions
Buy: 990 980 | Sell: 225 368

Forecast: 16:00 - $14.17

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $14.17
Forecast 2: 16:00 - $14.17
Forecast 3: 16:00 - $14.17
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $14.17 (-1.25% )
Volume 0.102 mill
Avg. Vol. 0.0779 mill
% of Avg. Vol 130.41 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Entrada Therapeutics, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Entrada Therapeutics, Inc.

RSI

Intraday RSI14 chart for Entrada Therapeutics, Inc.

Last 10 Buy & Sell Signals For TRDA

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:18sell$14.52N/AActive
Profile picture for
            Entrada Therapeutics, Inc.

TRDA

Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also engages in the development of EEV-PMO-CAG for the treatment of myotonic dystrophy type 1. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Last 10 Buy Signals

Date Signal @
DCRUSDMar 29 - 08:30$28.20
RBNUSDMar 29 - 08:301.670
GTUSDMar 29 - 08:30$9.91
BORAUSDMar 29 - 08:29$0.227
ATORUSDMar 29 - 08:293.34
IONUSDMar 29 - 08:24451.18
RADUSDMar 29 - 08:24$3.39
XVSUSDMar 29 - 08:20$16.04
SAVAXUSDMar 29 - 08:1961.03
RSS3USDMar 29 - 08:190.550

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.